For instance, those allergic to cobalt or with Leber's disease should avoid vitamin B12 injections
CagriSema, but also emerging research on combinations of triple agonists with amylin analogs, GLP-1 agonists with calcitonin receptor agonists, and other multi-pathway approaches
Absolute contraindications include active malignancy, pregnancy, and lactation
Behavioral or emotional changes
Oral administration in GI-specific research For GI-focused protocols gastric ulcer, colitis, IBD, NSAID-induced enteropathy, hepatic protection oral administration is the logical primary route given: Direct delivery to the affected tissue Alignment with the peptides biological origin (gastric-juice fragment) Established preclinical precedent In these indications, oral dosing is often the primary route rather than a convenience alternative